MGIM
ORGO icon

M&G Investment Management’s Organogenesis Holdings ORGO Stock Holding History

M&G Investment Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-168,694
Closed -$1.52K – 500
2021
Q4 		$1.52K Sell
168,694
-319,767
-65% -$3.4M ﹤0.01% 335
2021
Q3 		$6.84K Buy
488,461
+98,775
+25% +$1.53M 0.02% 342
2021
Q2 		$6.63K Buy
+389,686
New +$7.26M 0.02% 349

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

M&G Investment Management's ORGO Position: Q1 2022 in Review

M&G Investment Management sold out of Organogenesis Holdings (ORGO) in Q1 2022, closing a stake of 168,694 shares — an estimated $1.52K sold.

M&G Investment Management first reported a position in ORGO in Q2 2021 and held it in 3 quarters. The position peaked at $6.84K in Q3 2021. 156 funds tracked by Wall St. Rank hold ORGO as of Q1 2022.

  • M&G Investment Management reported no remaining Organogenesis Holdings position as of Q1 2022 after selling out during the quarter.
  • M&G Investment Management sold 168,694 Organogenesis Holdings shares in Q1 2022, an estimated $1.52K.
  • M&G Investment Management first reported a position in Organogenesis Holdings in Q2 2021 and held it in 3 quarters.
  • M&G Investment Management's Organogenesis Holdings position peaked at $6.84K in Q3 2021.
  • 156 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2022.

Based on M&G Investment Management's 13F filing for Q1 2022, filed 13 May 2022.